Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 7/20 | 0.37 |
| ▸ | CTSD | P07339 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP7 | P09237 | 1/20 | 0.30 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | ECE1 | P42892 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6906656 | 0.87 | TLR4 (0.39) | TLR4 | |
| SCHEMBL1238048 | 0.82 | CYP2D6 (0.44) | CYP2D6KMT2ACA1CA2CA4 | |
| SCHEMBL1238202 | 0.78 | CYP2D6 (0.43) | CYP2D6 | |
| SCHEMBL913008 | 0.77 | CYP2D6 (0.39) | CYP2D6 | |
| SCHEMBL11903954 | 0.76 | CYP2D6 (0.43) | CYP2D6 | |
| SCHEMBL7632295 | 0.76 | KMT2A (0.48) | CYP2D6KMT2ACA1CA2CA4 | |
| SCHEMBL6906311 | 0.76 | KMT2A (0.48) | CYP2D6KMT2ACA1CA2CA4 | |
| SCHEMBL6907712 | 0.76 | KMT2A (0.48) | CYP2D6KMT2ACA1CA2CA4 | |
| SCHEMBL6907608 | 0.76 | KMT2A (0.48) | CYP2D6KMT2ACA1CA2CA4 | |
| SCHEMBL6907464 | 0.74 | CYP2D6 (0.46) | CYP2D6KMT2ACA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020143070-A1 | Noxious-insect repellent | KANEBO, LTD. | 2002-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143070-A1 | Noxious-insect repellent | OPRM1, OPRD1, L3MBTL1 | BACE1 1347/4885CTSD 4501/4885CYP2D6 1959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.